Many of Australia’s top brokers have been busy adjusting their financial models again, leading to the release of a large number of broker notes this week.
Three broker buy ratings that have caught my eye are summarised below. Here’s why brokers think these ASX shares are in the buy zone:
Bigtincan Holdings Ltd (ASX: BTH)
According to a note out of Morgan Stanley, its analysts have retained their overweight rating and lifted their price target on this sales enablement software company’s shares to $2.10. This follows the announcement of the acquisition of Brainshark for what the broker feels is a very reasonable price. Morgan Stanley was pleased with the news and believes it will help the company reach profitability sooner than previously expected. The Bigtincan share price is trading at $1.46 on Wednesday.
SEEK Limited (ASX: SEK)
A note out of Macquarie reveals that its analysts have retained their outperform rating but trimmed their price target on this job listings company’s shares to $37.00. This is despite the release of a softer than expected full year result earlier this week. While Macquarie has lowered its estimates, it still sees a lot of value in the company’s shares at the current level and has retained its outperform rating. The SEEK share price was fetching $31.65 this afternoon.
Sonic Healthcare Limited (ASX: SHL)
Analysts at Morgans have retained their add rating and lifted their price target on this healthcare company’s shares to $45.98. This follows the release of a strong full year result for FY 2021 earlier this week. Looking ahead, Morgans is confident in the company’s outlook due to strong demand for COVID testing, its solid base business, strong balance sheet, and acquisition opportunities. This has led to the broker upgrading its earnings forecasts for the coming years. The Sonic share price is trading at $42.35 on Wednesday afternoon.